| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0009 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.001 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.001 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.14 | 0.001 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.001 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | 0.24 | 0.001 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.001 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.094 | 0.002 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |